Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene.
Most papers first4,141 to 4,160 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| NPS neuropeptide S | 594857 HGNC:33940 | 1 | 27 | 0 | 0 | 641 | 1,321 |
| IFNLR1 interferon lambda receptor 1 | 163702 HGNC:18584 | 1 | 130 | 1 | 22 | 1,015 | 1,320 |
| GLIS3 GLIS family zinc finger 3 | 169792 HGNC:28510 | 1 | 31 | 0 | 0 | 1,276 | 1,319 |
| OSBP oxysterol binding protein | 5007 HGNC:8503 | 1 | 22 | 0 | 0 | 752 | 1,319 |
| RPP14 ribonuclease P/MRP subunit p14 | 11102 HGNC:30327 | 1 | 54 | 0 | 0 | 928 | 1,319 |
| GRB7 growth factor receptor bound protein 7 | 2886 HGNC:4567 | 1 | 44 | 0 | 0 | 924 | 1,318 |
| LCP1 lymphocyte cytosolic protein 1 | 3936 HGNC:6528 | 1 | 39 | 0 | 0 | 909 | 1,318 |
| TMEM37 transmembrane protein 37 | 140738 HGNC:18216 | 1 | 12 | 0 | 0 | 533 | 1,318 |
| APTX aprataxin | 54840 HGNC:15984 | 1 | 12 | 0 | 0 | 727 | 1,316 |
| CIP2A cellular inhibitor of PP2A | 57650 HGNC:29302 | 1 | 26 | 0 | 0 | 663 | 1,316 |
| MAGEA4 MAGE family member A4 | 4103 HGNC:6802 | 1 | 183 | 1 | 0 | 479 | 1,316 |
| PPRC1 PPARG related coactivator 1 | 23082 HGNC:30025 | 1 | 18 | 0 | 0 | 1,053 | 1,316 |
| SEA S13 erythroblastosis (avian) oncogene homolog | 6395 | 0 | 0 | 0 | 0 | 408 | 1,316 |
| SMS spermine synthase | 6611 HGNC:11123 | 1 | 26 | 0 | 0 | 748 | 1,316 |
| ZFHX3 zinc finger homeobox 3 | 463 HGNC:777 | 1 | 25 | 0 | 0 | 1,248 | 1,316 |
| DPYSL5 dihydropyrimidinase like 5 | 56896 HGNC:20637 | 1 | 35 | 0 | 0 | 415 | 1,315 |
| IDO2 indoleamine 2,3-dioxygenase 2 | 169355 HGNC:27269 | 1 | 12 | 0 | 0 | 618 | 1,314 |
| RACGAP1 Rac GTPase activating protein 1 | 29127 HGNC:9804 | 1 | 74 | 0 | 0 | 715 | 1,314 |
| RTN4R reticulon 4 receptor | 65078 HGNC:18601 | 1 | 383 | 0 | 0 | 834 | 1,314 |
| ANKRD1 ankyrin repeat domain 1 | 27063 HGNC:15819 | 1 | 26 | 0 | 0 | 974 | 1,313 |
Code
curl "https://conductscience.org/api/genes/v1?page=208"
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=208
{
"data": {
"total": 193990,
"results": [
{
"id": "594857",
"title": "NPS: neuropeptide S",
"summary": "NCBI Gene 594857. 1 protein, 27 patents, 0 drugs, 0 trials, 641 NIH grants and 1,321 papers.",
"record": "/library/genes/594857",
"gene_id": 594857,
"symbol": "NPS",
"name": "neuropeptide S",
"hgnc_id": "HGNC:33940",
"counts": {
"proteins": 1,
"patents": 27,
"drugs": 0,
"trials": 0,
"grants": 641,
"papers": 1321
}
},
{
"id": "163702",
"title": "IFNLR1: interferon lambda receptor 1",
"summary": "NCBI Gene 163702. 1 protein, 130 patents, 1 drug, 22 trials, 1,015 NIH grants and 1,320 papers.",
"record": "/library/genes/163702",
"gene_id": 163702,
"symbol": "IFNLR1",
"name": "interferon lambda receptor 1",
"hgnc_id": "HGNC:18584",
"counts": {
"proteins": 1,
"patents": 130,
"drugs": 1,
"trials": 22,
"grants": 1015,
"papers": 1320
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.2.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "No license stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "Public domain (US government)"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubMed",
"license": "NLM's terms",
"notice": null,
"short": "NLM's terms"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=209",
"request_id": "haflr4Vp94FmYHL5"
}Ask about these results. The first 10 go in the prompt.
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
Opens sequences.conductscience.org
Open Targets
One drug with its targets, the diseases it is studied for, and the trials that name it, with their comparisons, papers and cognitive tests.
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant